Abstract:Testicular rhabdomyosarcoma is relatively rare in testicular tumors, but the age of patient is relatively young and the degree of malignancy is high. Therefore, this article introduces 4 cases of testicular rhabdomyosarcoma who were admitted to Peking University Third Hospital from May 1994 to February 2019, and reviews the literature to improve the diagnosis and treatment of this disease. The average age of the 4 patients was 17.5 years (14-21 years), the average hospital stay was 22.0 d (17-31 d), and the average body mass index was 19.6 kg/m2 (14.7-25.8 kg/m2). All the patients underwent routine preoperative blood and urine routine, biochemical tests, as well as serum tumor markers. Preoperative examinations also included chest radiograph, electrocardiogram, ultrasound of the scrotum and groin, and abdominal enhanced CT. Lung CT or other examinations were performed if necessary. The median serum human chorionic gonadotropin (HCG) of the 4 patients was 0.20 IU/L (0.06-0.86 IU/L) (all normal), and the median serum alpha-fetoprotein (AFP) was 1.03 g/L (0.65-1.66 g/L) (all normal). The average maximum diameter of the tumor was 10.0 cm (4.5-15.0 cm). Testicular rhabdomyosarcoma was mainly diagnosed by pathology. The main treatment was radical orchiectomy combined with retroperitoneal lymph node dissection, with or without postoperative adjuvant chemotherapy. The clinical manifestations of the patients with testicular rhabdomyosarcoma had no specific characteristics, but most patients were young at onset with mainly painless masses in the testicles, which were already large when they were found. Patients with testicular rhabdomyosarcoma have a poor prognosis, most of whom recur within two years. Because of the small number of cases of testicular rhabdomyosarcoma, there is no standard treatment currently. It is recommended that patients with testicular rhabdomyosarcoma undergo radical testicular resection combined with retroperitoneal lymph node dissection. Retroperitoneal lymph node metastasis is an important prognostic factor, and patients with postoperative adjuvant chemotherapy can still survive for a longer time. If local recurrence or limited metastasis is found after operation, local resection and salvage radiotherapy are feasible.

[Paratesticular Embryonal Rhabdomyosarcoma: Report of 5 Cases and Review of the Literature].

Sarcomatoid carcinoma of the renal pelvis: Experience of multiple cases over a ten-year period.

[Transperitoneal Laparoscopic Modified Lymph Node Dissection for Clinical Stage I Nonseminomatous Germ Cell Testicular Carcinoma].

Paratesticular rhabdomyosarcoma (report of 3 cases)

[The Surgical Therapy of Periacetabular Malignant Tumors].

Deep Sarcoma of the Penis: A Report of 2 Cases and Review of the Literature

Diagnosis and treatment of testicular embryonal rhabdomyosarcoma(3 cases report)

Paratesticular fetal-type rhabdomyoma in a 12-year-old boy: a case report and literature review.

Perianal embryonal rhabdomyosarcoma: A case report

Extramammary Paget's Disease of Scrotum-Report of 25 Cases and Literature Review

Periosteal osteosarcoma and high grade surface osteosarcoma

Case report: Two cases of primary paratesticular liposarcoma

[Clinical Analysis of 15 Cases of Paget's Disease of the Scrotum].

Adult paratesticular rhabdomyosarcoma(report 2 cases)

Clinical Analysis of Testicular Rhabdomyosarcoma

Perianal and perineal rhabdomyosarcomas: a retrospective multicenter study of 35 cases

Comprehensive treatment of primary pelvic synovial sarcoma: A 28-month follow-up case report and review of the literature

Epidemiologic Study of 230 Cases of Testicular/paratesticular Tumors or Masses: 15-Year Experience of a Single Center

Primary retroperitoneal seminoma:A case reportand review of literature

[Treatment and Prognosis of Scrotal Extramammary Paget's Disease: a Report of 23 Cases].

Diagnosis and treatment of adult paratesticular rhabdomyosarcoma (report of 5 cases)